MRNA Exercise Disclosure
Hoge Stephen · SEC Form 4 · Filed Sep 16, 2026
Exercise
Calculated transaction value
$0
Hoge Stephen President
MRNA
Moderna
MRNA
Transaction date
Sep 15, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 1 day later
MRNA daily price context
Close on/before transaction
$143.77
Sep 15, 2026
Close before public filing
$143.77
Sep 15, 2026
Return since public filing
+7.14%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 76,452 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001682852-26-000176
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$13.56M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Moderna, Inc. MRNA | Exercise | Sep 15, 2026 | $933.48K |
| Moderna, Inc. MRNA | Sale | Sep 15, 2026 | $5.88M |
| Moderna, Inc. MRNA Current | Exercise | Sep 15, 2026 | $0 |
| Moderna, Inc. MRNA | Exercise | Sep 14, 2026 | $933.49K |
| Moderna, Inc. MRNA | Sale | Sep 14, 2026 | $5.81M |
| Moderna, Inc. MRNA | Exercise | Sep 14, 2026 | $0 |